Latest news
USA TODAY Co. Announces Second Quarter Results & Reiterates Business Outlook - Business WireBusiness Wire · Thu, 06 Aug 2026 12:00:00 GMTU.S. FDA Accepts sBLA for ENFLONSIA™ (clesrovimab-cfor) to Update its Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease Indication to Include Children Under Two Years at Increased Risk for Severe RSV for Their Second Season - Business WireBusiness Wire · Thu, 06 Aug 2026 10:45:00 GMTTernium Announces Second Quarter and First Half of 2026 Results - USA TodayUSA Today · Wed, 05 Aug 2026 01:44:35 GMTMerck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline - Business WireBusiness Wire · Tue, 04 Aug 2026 10:30:00 GMT